Bay Street News

CTS Announces Second Quarter 2024 Results

LISLE, Ill., July 30, 2024 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that “Sense, Connect and Move,” today announced second quarter 2024 results.

“We achieved earnings in line with our expectations, despite softness in the transportation end market. We made progress on operational improvements, which helped partially offset the unfavorable impact from lower volumes.” said Kieran O’Sullivan, CEO of CTS Corporation. “Our team is energized on future growth through continued diversification of our customer base and building our pipeline of opportunities. We remain committed to a disciplined capital structure to support organic growth, strategic acquisitions and returning cash to shareholders.”

CTS completed the acquisition of SyQwest, LLC on July 29, 2024 for $125 million, net of cash and debt, and contingent consideration. SyQwest is a leading designer and manufacturer of a broad set of sonar and acoustic sensing solutions primarily for naval applications. “SyQwest adds strong technical capabilities and enhances our scale in underwater acoustic applications in the defense end market, further advancing our diversification strategy,” said Kieran O’Sullivan. “We are excited about the growth momentum and welcome Bob Tarini and the SyQwest team to CTS.”

Second Quarter 2024 Results

2024 Guidance

Given the more moderate growth expectations in the second half of 2024, CTS is updating its guidance for full year 2024 sales to be in the range of $525 – $540 million and adjusted diluted EPS to be in the range of $2.05 – $2.25, including the expected impact from the SyQwest acquisition.

CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS’ control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information.

Conference Call and Supplemental Materials
As previously announced, the Company has scheduled a conference call for 10:00 a.m. (ET) today. The dial-in numbers for access from the U.S. are: +1-833-470-1428 (Toll-Free) and +1-404-975-4839 (Local), if calling from outside the U.S., please refer to Global Dial In Numbers to identify the applicable dial-in number for your location. The passcode is 325452. In addition, the Company will be using a supplemental slide presentation that will be referred to during the call. The presentation and a live audio webcast of the conference call will be available and can be accessed directly from CTS’ website at https://investors.ctscorp.com/news-events/events-and-presentations/.

Any replay, rebroadcast, transcript or other reproduction or transmission of this conference call, other than the replay accessible through the website noted above, has not been authorized by the Company and is strictly prohibited. Investors should be aware that any unauthorized reproduction of this conference call may not be an accurate reflection of its contents.

About CTS

CTS Corporation (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical and transportation markets. For more information, visit www.ctscorp.com
  
Cautionary Statement Regarding Forward-Looking Statements

Readers are cautioned that the statements contained in this document regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are, or may be deemed to be, “forward-looking statements” as defined by the “safe harbor” provisions in the Private Securities Litigation Reform Act of 1995. Such statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, included or incorporated in this document, including statements regarding our strategy, financial position, guidance, funding for continued operations, cash reserves, liquidity, projected costs, plans, projects, awards and contracts, and objectives of management, among others, are forward-looking statements. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “continued,” “project,” “plan,” “goals,” “opportunity,” “appeal,” “estimate,” “potential,” “predict,” “demonstrates,” “may,” “will,” “might,” “could,” “intend,” “shall,” “possible,” “would,” “approximately,” “likely,” “outlook,” “schedule,” “on track,” “poised,” “pipeline,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are not guarantees of future performance, conditions or results. Forward-looking statements are based on management’s expectations, certain assumptions, and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties, and other factors, which could cause CTS’ actual results, performance, or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: supply chain disruptions; changes in the economy generally, including inflationary and/or recessionary conditions, and in respect to the business in which CTS operates; unanticipated issues in integrating acquisitions, including, without limitation, the integration of SyQwest, LLC; the results of actions to reposition CTS’ business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; risks associated with CTS’ international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks (including, without limitation, the potential impact U.S./China relations and the conflict between Russia and Ukraine may have on our business, results of operations and financial condition); the amount and timing of any share repurchases; and the effect of any cybersecurity incidents on our business. Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS’ most recent Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS’ forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes. 

Contact
Ashish Agrawal
Vice President and Chief Financial Officer
CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532 USA
+1 (630) 577-8800
ashish.agrawal@ctscorp.com

CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OFEARNINGS– UNAUDITED
(In thousands, except per share amounts)
 
   
    Three Months Ended     Six Months Ended  
    June 30,
2024
    June 30,
2023
    June 30,
2024
    June 30,
2023
 
Net sales   $ 130,162     $ 145,182     $ 255,912     $ 291,176  
Cost of goods sold     83,790       94,440       164,450       188,782  
Gross margin     46,372       50,742       91,462       102,394  
Selling, general and administrative expenses     21,332       23,694       43,591       45,673  
Research and development expenses     6,086       6,721       12,687       13,307  
Restructuring charges     1,190       1,895       2,884       2,807  
Operating earnings     17,764       18,432       32,300       40,607  
Other (expense) income:                        
Interest expense     (833 )     (818 )     (1,635 )     (1,512 )
Interest income     1,441       1,072       2,827       2,135  
Other expense, net     (603 )     (2,606 )     (2,066 )     (2,441 )
Total other income (expense), net     5       (2,352 )     (874 )     (1,818 )
Earnings before income taxes     17,769       16,080       31,426       38,789  
Income tax expense     3,062       3,183       5,600       7,548  
Net earnings   $ 14,707     $ 12,897     $ 25,826     $ 31,241  
Earnings per share:                        
Basic   $ 0.48     $ 0.41     $ 0.84     $ 0.99  
Diluted   $ 0.48     $ 0.41     $ 0.84     $ 0.98  
Basic weighted – average common shares outstanding:     30,511       31,488       30,627       31,560  
Effect of dilutive securities     219       197       224       224  
Diluted weighted – average common shares outstanding:     30,730       31,685       30,851       31,784  
Cash dividends declared per share   $ 0.04     $ 0.04     $ 0.08     $ 0.08  
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands of dollars)
 
    (Unaudited)
June 30,
2024
    December 31,
2023
 
ASSETS            
Current Assets            
Cash and cash equivalents   $ 161,246     $ 163,876  
Accounts receivable, net     85,380       78,569  
Inventories, net     51,670       60,031  
Other current assets     16,566       16,873  
Total current assets     314,862       319,349  
Property, plant and equipment, net     91,759       92,592  
Operating lease assets, net     24,181       26,425  
Other Assets            
Goodwill     156,061       157,638  
Other intangible assets, net     96,827       103,957  
Deferred income taxes     26,619       25,183  
Other     15,313       16,023  
Total other assets     294,820       302,801  
Total Assets   $ 725,622     $ 741,167  
LIABILITIES AND SHAREHOLDERS’ EQUITY            
Current Liabilities            
Accounts payable   $ 40,864     $ 43,499  
Accrued payroll and benefits     15,286       14,585  
Operating lease obligations     4,371       4,394  
Accrued expenses and other liabilities     31,926       34,561  
Total current liabilities     92,447       97,039  
Long-term debt     65,000       67,500  
Long-term operating lease obligations     22,741       24,965  
Long-term pension obligations     4,583       4,655  
Deferred income taxes     14,314       14,729  
Other long-term obligations     3,786       5,457  
Total Liabilities     202,871       214,345  
Commitments and Contingencies            
Shareholders’ Equity            
Common stock     321,894       319,269  
Additional contributed capital     41,586       45,097  
Retained earnings     625,614       602,232  
Accumulated other comprehensive loss     775       4,264  
Total shareholders’ equity before treasury stock     989,869       970,862  
Treasury stock     (467,118 )     (444,040 )
Total shareholders’ equity     522,751       526,822  
Total Liabilities and Shareholders’ Equity   $ 725,622     $ 741,167  
                 

CTS CORPORATION AND SUBSIDIARIES
OTHER SUPPLEMENTAL INFORMATION – UNAUDITED
(In millions of dollars, except percentages and per share amounts)

Non-GAAP Financial Measures

From time to time, CTS may use non-GAAP financial measures in discussing CTS’ business. These measures are intended to supplement, not replace, CTS’ presentation of its financial results in accordance with U.S. GAAP. CTS believes that the non-GAAP financial measures presented are commonly used by financial analysts and others in the industries in which CTS operates, and thus further provide useful information to investors. CTS’ definitions of these non-GAAP financial measures may differ from those terms as defined or used by other companies. Non-GAAP measures should not be used by investors or third parties as the sole basis for formulating investment decisions, as they may exclude a number of important cash and non-cash recurring items.

CTS has presented these non-GAAP financial measures as it believes that the presentation of its financial results that exclude (1) restructuring charges; (2) restructuring-related charges; (3) environmental charges; (4) acquisition-related costs; (5) inventory fair value step-up costs; (6) foreign exchange (gains) losses; (7) non-cash pension expenses (income); and (8) certain discrete tax items are useful and assist in comparing CTS’ current operating results with past periods and with the operational performance of other companies in its industry. Included below is a description of the expenses that CTS has determined are not normal, recurring cash operating expenses necessary to operate its business and the rationale for why providing financial measures for its business with such expenses excluded or adjusted is useful to investors as a supplement to the U.S. GAAP measures.

At times, the reconciliations below have been intentionally rounded to the nearest thousand, or $0.01 for EPS figures, and, therefore, may not sum.

Adjusted Gross Margin

    Three Months Ended
June 30,
    Six Months Ended
June 30,
    Twelve Months Ended
December 31,
 
    2024     2023     2024     2023     2023     2022     2021  
Gross margin   $ 46.4     $ 50.7     $ 91.5     $ 102.4     $ 190.9     $ 210.5     $ 184.6  
                                           
Net sales   $ 130.2     $ 145.2     $ 255.9     $ 291.2     $ 550.4     $ 586.9     $ 512.9  
                                           
Gross margin as a % of net sales     35.6 %     35.0 %     35.7 %     35.2 %     34.7 %     35.9 %     36.0 %
                                           
Adjustments to reported gross margin:                                          
Restructuring-related charges (b)     0.2             0.7             0.6              
Inventory fair value step-up (b)                                   4.0        
                                           
Adjusted gross margin   $ 46.6     $ 50.7     $ 92.2     $ 102.4     $ 191.5     $ 214.5     $ 184.6  
                                           
Adjusted gross margin as a % of net sales     35.8 %     35.0 %     36.0 %     35.2 %     34.8 %     36.5 %     36.0 %


Adjusted Operating Earnings

    Three Months Ended
June 30,
    Six Months Ended
June 30,
    Twelve Months Ended
December 31,
 
    2024     2023     2024     2023     2023     2022     2021  
Operating earnings   $ 17.8     $ 18.4     $ 32.3     $ 40.6     $ 75.1     $ 93.0     $ 76.5  
                                           
Net sales   $ 130.2     $ 145.2     $ 255.9     $ 291.2     $ 550.4     $ 586.9     $ 512.9  
                                           
Operating earnings as a % of net sales     13.6 %     12.7 %     12.6 %     13.9 %     13.6 %     15.8 %     14.9 %
                                           
Adjustments to reported operating earnings:                                          
Restructuring charges (c)     1.2       1.9       2.9       2.8       7.1       1.9       1.7  
Restructuring-related charges (b)     0.2             0.7             0.6              
Environmental charges (a)     0.5       2.2       0.7       2.7       3.5       2.8       2.3  
Acquisition-related costs (a)     (0.3 )           (0.6 )     0.2       0.4       0.8        
Inventory fair value step-up (b)                                   4.0        
Total adjustments to reported operating earnings   $ 1.6     $ 4.1     $ 3.8     $ 5.7     $ 11.5     $ 9.5     $ 3.9  
                                           
Adjusted operating earnings   $ 19.4     $ 22.5     $ 36.1     $ 46.3     $ 86.6     $ 102.5     $ 80.4  
                                           
Adjusted operating earnings as a % of net sales     14.9 %     15.5 %     14.1 %     15.9 %     15.7 %     17.5 %     15.7 %


Adjusted EBITDA Margin

    Three Months Ended
June 30,
    Six Months Ended
June 30,
    Twelve Months Ended
December 31,
 
    2024     2023     2024     2023     2023     2022     2021  
Net earnings (loss)   $ 14.7     $ 12.9     $ 25.8     $ 31.2     $ 60.5     $ 59.6     $ (41.9 )
                                           
Net sales   $ 130.2     $ 145.2     $ 255.9     $ 291.2     $ 550.4     $ 586.9     $ 512.9  
                                           
Net earnings (loss) margin     11.3 %     8.9 %     10.1 %     10.7 %     11.0 %     10.2 %     -8.2 %
                                           
Depreciation and amortization expense     7.3       7.3       14.7       14.2       28.7       29.8       26.9  
Interest expense     0.8       0.8       1.6       1.5       3.3       2.2       2.1  
Tax expense (benefit)     3.1       3.2       5.6       7.5       14.6       21.2       (19.0 )
                                           
EBITDA     25.9       24.2       47.7       54.5       107.2       112.7       (31.8 )
                                           
Adjustments to EBITDA:                                          
Restructuring charges (c)     1.2       1.9       2.9       2.8       7.1       1.9       1.7  
Restructuring-related charges (b)     0.2             0.7             0.6              
Environmental charges (a)     0.5       2.2       0.7       2.7       3.5       2.8       2.3  
Acquisition-related costs (a)     (0.3 )           (0.6 )     0.2       0.4       2.5        
Inventory fair value step-up (b)                                   4.0        
Non-cash pension and related expense (d)     0.1             0.1                   4.8       132.4  
Foreign currency loss (d)     0.6       2.8       2.1       2.7       2.0       4.9       3.3  
                                           
Total adjustments to EBITDA     2.3       6.8       6.0       8.4       13.5       20.9       139.7  
                                           
Adjusted EBITDA   $ 28.2     $ 31.0     $ 53.7     $ 62.9     $ 120.7     $ 133.6     $ 107.9  
                                           
Adjusted EBITDA Margin     21.7 %     21.3 %     21.0 %     21.6 %     21.9 %     22.8 %     21.0 %


Adjusted Net Earnings and Adjusted Diluted Earnings Per Share

    Three Months Ended
June 30,
    Six Months Ended
June 30,
   
    2024     2024     2023     2023     2024     2024     2023     2023    
          Per share           Per share           Per share           Per share    
Net earnings (A)   $ 14.7     $ 0.48     $ 12.9     $ 0.41     $ 25.8     $ 0.84     $ 31.2     $ 0.98    
                                                   
Adjustments to reported net earnings:                                                  
Restructuring charges (c)     1.2       0.04       1.9       0.06       2.9       0.09       2.8       0.09    
Restructuring-related charges (b)     0.2       0.01                   0.7       0.02                
Environmental charges (a)     0.5       0.02       2.2       0.07       0.7       0.02       2.7       0.09    
Acquisition-related costs (a)     (0.3 )     (0.01 )                 (0.6 )     (0.02 )     0.2       0.00    
Non-cash pension and related expense (d)     0.1                         0.1                      
Foreign currency loss (d)     0.6       0.02       2.8       0.09       2.1       0.07       2.7       0.08    
Total pretax adjustments to reported net earnings   $ 2.3     $ 0.07     $ 6.8     $ 0.21     $ 6.0     $ 0.19     $ 8.4     $ 0.26    
Income tax effect of above adjustments (f)     (0.5 )     (0.02 )     (0.9 )     (0.03 )     (1.0 )     (0.03 )     (1.2 )     (0.04 )  
Total adjustments, tax affected (f)(B)   $ 1.8     $ 0.06     $ 5.9     $ 0.18     $ 5.0     $ 0.16     $ 7.2     $ 0.22    
                                                   
Tax adjustments:                                                  
Other discrete tax items (e)                             0.3       0.01                
Total tax adjustments(C)   $     $     $     $     $ 0.3     $ 0.01     $     $    
Adjusted net earnings (A+B+C) and Adjusted net earnings per share   $ 16.5     $ 0.54     $ 18.8     $ 0.59     $ 31.1     $ 1.01     $ 38.4     $ 1.20    
                                                   
Net sales   $ 130.2           $ 145.2           $ 255.9           $ 291.2          
                                                   
Net earnings as a % of net sales     11.3 %           8.9 %           10.1 %           10.7 %        
                                                   
Adjusted net earnings as a % of net sales     12.7 %           13.0 %           12.1 %           13.2 %        
     
    Twelve Months Ended
December 31,
     
    2023     2023     2022     2022     2021     2021      
          Per share           Per share           Per share      
Net earnings (loss) (A)   $ 60.5     $ 1.92     $ 59.6     $ 1.85     $ (41.9 )   $ (1.30 )    
                                         
Adjustments to reported net earnings (loss):                                        
Restructuring charges (c)     7.1       0.22       1.9       0.06       1.7       0.06      
Restructuring-related charges (b)     0.6       0.02                              
Environmental charges (a)     3.5       0.11       2.8       0.09       2.3       0.07      
Acquisition-related costs (a)     0.4       0.01       2.5       0.08                  
Inventory fair value step-up (b)                 4.0       0.12                  
Non-cash pension and related expense (d)                 4.8       0.15       132.4       4.10      
Foreign currency loss (d)     2.0       0.06       4.9       0.15       3.3       0.10      
Total pretax adjustments to reported net earnings (loss)   $ 13.5     $ 0.42     $ 20.9     $ 0.65     $ 139.7     $ 4.33      
Income tax effect of above adjustments (f)     (2.4 )     (0.07 )     (1.6 )     (0.05 )     (31.1 )     (0.99 )    
Total adjustments, tax affected (f)(B)   $ 11.1     $ 0.35     $ 19.3     $ 0.60     $ 108.6     $ 3.34      
                                         
Tax adjustments:                                        
Increase in valuation allowances (e)                             0.9       0.03      
Other discrete tax items (e)     (1.6 )     (0.05 )     0.2       0.01       (4.7 )     (0.14 )    
Total tax adjustments(C)   $ (1.6 )   $ (0.05 )   $ 0.2     $ 0.01     $ (3.8 )   $ (0.11 )    
Adjusted net earnings (A+B+C) and Adjusted net earnings per share   $ 70.0     $ 2.22     $ 79.1     $ 2.46     $ 63.0     $ 1.93      
                                         
Net sales   $ 550.4           $ 586.9           $ 512.9            
                                         
Net earnings (loss) as a % of net sales     11.0 %           10.2 %           -8.2 %          
                                         
Adjusted net earnings as a % of net sales     12.7 %           13.5 %           12.3 %          
                                               

(a) Reflected in selling, general and administrative and other (expense) income, net.
(b) Reflected in cost of goods sold.
(c) Reflected in restructuring charges.
(d) Reflected in other (expense) income, net.

(e) Reflected in income tax expense (income). For 2021, the discrete tax items relate to items we deemed outside normal cash-generating operations including, $5.4 million of a stranded tax benefit from the U.S. Pension termination offset by $0.7 million of tax expense from tax costs associated with a one-time internal cash movement, and $0.9 million related to the addition of a valuation allowance for a foreign subsidiary. For 2022, the discrete tax items relate to the net impact to tax expense of expired research and development credits, including the release of associated reserves. For 2023, discrete tax items include adjusting for tax benefits resulting from $0.6 million for research and development tax credits from prior years, $0.8 million in foreign tax credits related to prior years from a 2023 tax law change, as well as $0.2 million from the release of uncertain tax benefits. For 2024, the discrete tax items relate to items we deemed outside normal cash-generating operations including the addition of a valuation allowance for a foreign subsidiary.
(f) We determine the tax effect of non-GAAP adjustments by considering the tax laws and statutory income tax rates applicable in the tax jurisdictions of the underlying non-GAAP adjustments. For all periods presented, we applied the statutory income tax rates to the taxable portion of all of our adjustments. Our acquisition costs and foreign currency gains and losses included in our non-GAAP adjustments were not deductible for income tax purposes; therefore, no statutory income tax rate was applied to such costs.

NOTE: CTS believes that adjusted gross margin, adjusted operating earnings, adjusted EBITDA margin, adjusted net earnings and adjusted diluted earnings per share provide useful information to investors regarding its operational performance because they enhance an investor’s overall understanding of CTS’ core financial performance and facilitate comparisons to historical results of operations, by excluding items that are not related directly to the underlying performance of CTS’ fundamental business operations (such as those items noted above in the paragraph titled “Non-GAAP Financial Measures”) or were not part of CTS’ business operations during a comparable period.

Controllable Working Capital

    June 30,     December 31,  
    2024     2023     2023     2022     2021  
Net accounts receivable   $ 85.4     $ 97.5     $ 78.6     $ 90.9     $ 82.2  
                               
Net inventory   $ 51.7     $ 62.6     $ 60.0     $ 62.3     $ 49.5  
                               
Accounts payable   $ (40.9 )   $ (53.1 )   $ (43.5 )   $ (53.2 )   $ (55.5 )
                               
Controllable working capital   $ 96.2     $ 107.0     $ 95.1     $ 100.0     $ 76.2  
                               
Quarter sales   $ 130.2     $ 145.2     $ 124.7     $ 142.3     $ 132.5  
Multiplied by 4     4       4       4       4       4  
Annualized sales   $ 520.6     $ 580.7     $ 498.8     $ 569.1     $ 530.0  
                               
Controllable working capital as a % of annualized sales     18.5 %     18.4 %     19.1 %     17.6 %     14.4 %
                                         

NOTE: CTS believes the controllable working capital ratio is a useful measure because it provides an objective measure of the efficiency with which CTS manages its short-term capital needs.

Free Cash Flow

    Three Months Ended
June 30,
    Six Months Ended
June 30,
    Twelve Months Ended
December 31,
 
    2024     2023     2024     2023     2023     2022     2021  
Net cash provided by operating activities   $ 19.6     $ 23.4     $ 37.9     $ 34.6     $ 88.8     $ 121.2     $ 86.1  
Capital expenditures     (4.6 )     (3.9 )     (8.7 )     (8.5 )     (14.7 )     (14.3 )     (15.6 )
Free cash flow   $ 15.0     $ 19.5     $ 29.3     $ 26.1     $ 74.1     $ 106.9     $ 70.5  
                                           
Operating cash flow as a percentage of net earnings     133 %     181 %     147 %     111 %     147 %     203 %     -206 %
Free cash flow as a percentage of adjusted net earnings     91 %     103 %     94 %     68 %     106 %     135 %     112 %
 

NOTE: CTS believes that free cash flow is a useful measure because it demonstrates the company’s ability to generate cash. Free cash flow is a non-GAAP measure and should be considered in addition to, but not as a substitute for, information contained in the company’s condensed consolidated statement of cash flows as a measure of liquidity.

Capital Expenditures

    Three Months Ended
June 30,
    Six Months Ended
June 30,
    Twelve Months Ended
December 31,
 
    2024     2023     2024     2023     2023     2022     2021  
Capital expenditures   $ 4.6     $ 3.9     $ 8.7     $ 8.5     $ 14.7     $ 14.3     $ 15.6  
Net sales   $ 130.2     $ 145.2     $ 255.9     $ 291.2     $ 550.4     $ 586.9     $ 512.9  
Capex as % of net sales     3.6 %     2.7 %     3.4 %     2.9 %     2.7 %     2.4 %     3.0 %
                                                         

Additional Information

The following table includes other financial information not presented in the preceding financial statements.

    Three Months Ended
June 30,
    Six Months Ended
June 30,
    Twelve Months Ended
December 31,
 
    2024     2023     2024     2023     2023     2022     2021  
Depreciation and amortization expense   $ 7.3     $ 7.3     $ 14.7     $ 14.2     $ 28.7     $ 29.8     $ 26.9  
Stock-based compensation expense   $ 1.3     $ 1.6     $ 2.5     $ 3.2     $ 5.2     $ 7.7     $ 6.1  
                                                         


Bay Street News